Pablo Ramos

562 total citations
15 papers, 380 citations indexed

About

Pablo Ramos is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Pablo Ramos has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in Pablo Ramos's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Pablo Ramos is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Pablo Ramos collaborates with scholars based in Spain, United Kingdom and Italy. Pablo Ramos's co-authors include David Escors, Ester Blanco, Hugo Arasanz, Maider Garnica, Ana Bocanegra, Leticia Fernández, Luisa Chocarro, Miriam Echaide, Grazyna Kochan and Ruth Vera and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Cells.

In The Last Decade

Pablo Ramos

15 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Ramos Spain	10	272	210	62	49	23	15	380
Maider Garnica Spain	11	299 1.1×	229 1.1×	70 1.1×	54 1.1×	25 1.1×	20	423
Katrin Deiser Germany	10	240 0.9×	336 1.6×	85 1.4×	20 0.4×	15 0.7×	14	470
Koji Kurose Japan	10	228 0.8×	289 1.4×	52 0.8×	55 1.1×	16 0.7×	27	418
Juhi R. Kuchroo United States	7	232 0.9×	347 1.7×	79 1.3×	20 0.4×	21 0.9×	9	466
Jean David Fumet France	7	347 1.3×	140 0.7×	87 1.4×	85 1.7×	31 1.3×	14	409
Suzanne R. Thibodeaux United States	9	171 0.6×	219 1.0×	61 1.0×	25 0.5×	10 0.4×	28	387
Jichang Han China	6	167 0.6×	178 0.8×	60 1.0×	37 0.8×	18 0.8×	13	299
Jenna D. Goldberg United States	4	275 1.0×	106 0.5×	170 2.7×	27 0.6×	23 1.0×	12	467
Fiona He United States	10	259 1.0×	235 1.1×	62 1.0×	14 0.3×	17 0.7×	33	425
Sibgha Gull Chaudhary United States	8	162 0.6×	81 0.4×	70 1.1×	41 0.8×	11 0.5×	38	302

Countries citing papers authored by Pablo Ramos

Since Specialization

Citations

This map shows the geographic impact of Pablo Ramos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Ramos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Ramos more than expected).

Fields of papers citing papers by Pablo Ramos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Ramos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Ramos. The network helps show where Pablo Ramos may publish in the future.

Co-authorship network of co-authors of Pablo Ramos

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Ramos. A scholar is included among the top collaborators of Pablo Ramos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Ramos. Pablo Ramos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Cardiovascular Diseases. 12448–12448. 1 indexed citations

Garnica, Maider, Anna Aiello, Mattia Emanuela Ligotti, et al.. (2022). How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. International Journal of Molecular Sciences. 23(17). 9797–9797. 11 indexed citations

Chocarro, Luisa, Hugo Arasanz, Leticia Fernández, et al.. (2022). CAR-T Cells for the Treatment of Lung Cancer. Life. 12(4). 561–561. 14 indexed citations

Arasanz, Hugo, Ana Bocanegra, Idoia Morilla, et al.. (2022). Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 14(16). 3846–3846. 26 indexed citations

Aiello, Anna, Mattia Emanuela Ligotti, Maider Garnica, et al.. (2022). How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International Journal of Molecular Sciences. 23(17). 9880–9880. 16 indexed citations

Echaide, Miriam, Ibone Labiano, Ángela Fernández de Lascoiti, et al.. (2022). Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers. 14(18). 4464–4464. 9 indexed citations

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Inflammatory Diseases. 12447–12447. 1 indexed citations

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). Clinical landscape of LAG-3-targeted therapy. Immuno-Oncology Technology. 14. 100079–100079. 71 indexed citations

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Neurological Diseases. 12449–12449. 1 indexed citations

10.

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). Role of the next-generation immune checkpoint LAG-3 in response and resistance to cancer immunotherapy. 12446–12446. 1 indexed citations

11.

Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2022). Cutting-Edge CAR Engineering: Beyond T Cells. Biomedicines. 10(12). 3035–3035. 9 indexed citations

12.

Chocarro, Luisa, Ana Bocanegra, Ester Blanco, et al.. (2022). Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor. Cells. 11(15). 2351–2351. 55 indexed citations

13.

Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 22(7). 3736–3736. 20 indexed citations

14.

Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2021). 55P Clinical landscape of LAG-3-targeted therapy. Annals of Oncology. 32. S1362–S1362. 1 indexed citations

15.

Chocarro, Luisa, Ester Blanco, Miren Zuazo, et al.. (2021). Understanding LAG-3 Signaling. International Journal of Molecular Sciences. 22(10). 5282–5282. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact